Details for New Drug Application (NDA): 017697
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
The generic ingredient in KINEVAC is sincalide. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the sincalide profile page.
Suppliers and Packaging for NDA: 017697
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
KINEVAC | sincalide | INJECTABLE;INJECTION | 017697 | NDA | Bracco Diagnostics Inc. | 0270-0556 | 0270-0556-15 | 10 VIAL in 1 PACKAGE (0270-0556-15) / 5 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 0.005MG/VIAL | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Patent: | See Plans and Pricing | Patent Expiration: | Aug 16, 2022 | Product Flag? | Y | Substance Flag? | Delist Request? |
Expired US Patents for NDA 017697
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bracco | KINEVAC | sincalide | INJECTABLE;INJECTION | 017697-001 | Approved Prior to Jan 1, 1982 | See Plans and Pricing | See Plans and Pricing |
Bracco | KINEVAC | sincalide | INJECTABLE;INJECTION | 017697-001 | Approved Prior to Jan 1, 1982 | See Plans and Pricing | See Plans and Pricing |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription